PNN DigitalPNN Digital
    Facebook Twitter Instagram
    Sunday, August 24
    Trending
    • Atif Aslam Returns With His Longest-Ever North America Tour, Borderless 2025
    • India-US Trade Negotiations: EAM Jaishankar’s Fierce Stand On ’50 percent’ Tariffs
    • Historic Training on Pest Management in Food Sector Marks Milestone for India’s Food Safety Standards
    • Bigg Boss 19: Salman Khan Teases Contestants – A Shocking Season of Twists Begins!
    • HEC Infra Projects Limited Secures Rs 12.08 Cr Orders Across Water and Energy Infrastructure
    • Shocking Divorce Drama: Is Govinda Really Splitting from Sunita?
    • Sharani Ponguru Unveiled Safalta Ka Raasta – Road To Success, Season 5
    • TikTok’s Big India Tease: A Promising Comeback or Just Déjà Vu in HD?
    Submit News
    PNN DigitalPNN Digital
    Subscribe
    • Home
    • News
    • Business
    • Entertainment
    • National
    • Lifestyle
    • More
      • Sports
      • Health
      • Finance
      • Education
    PNN DigitalPNN Digital
    Home»Business

    Fredun Pharmaceuticals Net Profit Rises 64% YoY in Q1 FY26

    PNN NewsdeskPNN Newsdesk Business 2 Mins Read
    Fredun
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Mumbai (Maharashtra) [India], July 31: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and Animal Healthcare Products, has reported its Unaudited financials for Q1 FY26.

    Key Financial Highlights 

    Particulars (₹ Cr) Q1 FY26 Q1 FY25 YoY
    Total Income 119.86 78.81 52.08%
    EBITDA 16.99 10.48 62.15%
    EBITDA Margin (%) 14.18 13.30 88 BPS
    Net Profit 6.77 4.13 63.82%
    Net Profit Margin (%) 5.64 5.24 40 BPS
    Diluted EPS (₹) 14.33 8.79 63.03%

    Commenting on the financial performance Mr. Fredun Medhora, Managing Director, said “We are pleased to report a strong start to FY26 with a significant year-on-year growth in net profit and healthy improvement across all key financial metrics. Our performance reflects the successful execution of our growth strategy and the continued demand for our diversified portfolio across domestic and international markets. Our generics portfolio continues to strengthen, with over 1,200 products currently under registration. Our current order book stands at over ₹200 crore, providing strong revenue visibility and momentum for the upcoming quarters.

    We have entered the organized pet care market with the acquisition of a controlling stake in One Pet Stop through our subsidiary FRPL, giving us access to a loyal customer base and a tech-enabled, doorstep grooming service. This move complements our premium Freossi pet care range and strengthens our vision to grow as a holistic player in India’s rapidly expanding pet wellness space.

    The pharmaceutical and healthcare industry continues to see robust demand driven by increasing health awareness, focus on affordable care, and supportive regulatory frameworks. With our growing presence in generics, cosmeceuticals, nutraceuticals, mobility aids, and animal health products, we are well-positioned to capitalize on these opportunities. Looking ahead, we remain committed to enhancing value through consistent performance, product innovation, and expanding our global reach.”

    Q1 FY26 Key Business Highlights

    Upgrade in Credit Rating
    • Rating Upgrade:
    • Long-term rating upgraded to IVR BBB/Stable (from IVR BBB-/Stable)
    • Assigned IVR BBB/Stable / IVR A3+ for long/short-term facilities
    • Total amount rated: ₹139.64 Cr
    Acquisition of One Pet Stop
    • Entity Involved: Fredun Retail Pvt. Ltd. (FRPL), a wholly owned subsidiary.
    • Acquisition: FPRL acquires controlling stake in One Pet Stop Pvt. Ltd.

    If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

    64% YoY fredun pharmaceuticals Net Profit Rises
    PNN Newsdesk

    Keep Reading

    Atif Aslam Returns With His Longest-Ever North America Tour, Borderless 2025

    Historic Training on Pest Management in Food Sector Marks Milestone for India’s Food Safety Standards

    HEC Infra Projects Limited Secures Rs 12.08 Cr Orders Across Water and Energy Infrastructure

    Sharani Ponguru Unveiled Safalta Ka Raasta – Road To Success, Season 5

    Hollywood Actor-Producer Prashant Rai Unveils “Pyar Da Rang” : A Soul-Stirring First Ever AI-Created Tribute Inspired by the Air India Ahmedabad Crash

    Kochi Blue Tigers ease past Trivandrum Royals with eight-wicket win

    Recent Posts
    • Atif Aslam Returns With His Longest-Ever North America Tour, Borderless 2025
    • India-US Trade Negotiations: EAM Jaishankar’s Fierce Stand On ’50 percent’ Tariffs
    • Historic Training on Pest Management in Food Sector Marks Milestone for India’s Food Safety Standards
    • Bigg Boss 19: Salman Khan Teases Contestants – A Shocking Season of Twists Begins!
    • HEC Infra Projects Limited Secures Rs 12.08 Cr Orders Across Water and Energy Infrastructure

    Atif Aslam Returns With His Longest-Ever North America Tour, Borderless 2025

    23/08/2025

    India-US Trade Negotiations: EAM Jaishankar’s Fierce Stand On ’50 percent’ Tariffs

    23/08/2025

    Historic Training on Pest Management in Food Sector Marks Milestone for India’s Food Safety Standards

    23/08/2025

    Bigg Boss 19: Salman Khan Teases Contestants – A Shocking Season of Twists Begins!

    23/08/2025

    HEC Infra Projects Limited Secures Rs 12.08 Cr Orders Across Water and Energy Infrastructure

    23/08/2025

    Shocking Divorce Drama: Is Govinda Really Splitting from Sunita?

    23/08/2025
    Facebook Instagram Twitter
    • Legal Disclaimer
    • Privacy Policy
    • Contact Us
    • About Us
    © 2025 PNN Digital. Designed by Primex Media Services.

    Type above and press Enter to search. Press Esc to cancel.